Inspire Trust Company’s Biogen BIIB Stock Holding History

Inspire Trust Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32M	Hold	20,000	–	–	0.59%	71
2026 Q1	$3.67M	Hold	20,000	–	–	0.57%	73
2025 Q4	$3.52M	Hold	20,000	–	–	0.58%	75
2025 Q3	$2.8M	Buy	20,000 +2,000	+11%	+$270K	0.51%	80
2025 Q2	$2.26M	Buy	18,000 +3,700	+26%	+$461K	0.47%	85
2025 Q1	$1.96M	Buy	14,300 +2,000	+16%	+$286K	0.47%	85
2024 Q4	$1.88M	Buy	12,300 +1,400	+13%	+$236K	0.48%	83
2024 Q3	$2.11M	Buy	10,900 +4,025	+59%	+$842K	0.58%	70
2024 Q2	$1.59M	Buy	6,875 +2,100	+44%	+$456K	0.53%	72
2024 Q1	$1.03M	Buy	4,775 +2,500	+110%	+$586K	0.57%	68
2023 Q4	$589K	Buy	+2,275	New	+$559K	0.61%	58

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inspire Trust Company's BIIB Position: Q2 2026 in Review

Inspire Trust Company held its Biogen (BIIB) position steady in Q2 2026 at 20,000 shares worth $4.32M. The position accounts for 0.59% of the portfolio, ranked #71.

Inspire Trust Company first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Inspire Trust Company held 20,000 shares of Biogen worth $4.32M as of Q2 2026.
Inspire Trust Company left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.59% of Inspire Trust Company's portfolio in Q2 2026, its #71 holding.
Inspire Trust Company first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Inspire Trust Company's 13F filing for Q2 2026, filed 5 Aug 2026.